The largest purchase of all time was on 2013-12-04 and amounted to 6000 shares of Galectin Therapeutics Inc. for $52,140.
The largest sale of all time was on 2018-08-30 and amounted to 58100 shares of Galectin Therapeutics Inc. for $353,312.
No biography is available at this moment.
| 2019-02-22 | Sale | Galectin Therapeutics Inc. GALT | director | 859 0.002% | $6.02 | $5,175 | -31.62% | |
| 2019-02-21 | Sale | Galectin Therapeutics Inc. GALT | director | 50,326 0.1119% | $6.02 | $303,026 | -35.96% | |
| 2019-01-23 | Sale | Curis, Inc. CRIS | director | 18,500 0.0549% | $1.05 | $19,477 | +68.22% | |
| 2018-09-04 | Sale | Galectin Therapeutics Inc. GALT | director | 11,900 0.0292% | $6.58 | $78,256 | -29.2% | |
| 2018-08-30 | Sale | Galectin Therapeutics Inc. GALT | director | 58,100 0.1473% | $6.08 | $353,312 | -20.65% | |
| 2017-12-08 | Galectin Therapeutics Inc. GALT | director | 14,000 0.0301% | $1.85 | $25,943 | +95.68% | ||
| 2017-11-16 | Curis, Inc. CRIS | director | 25,000 0.0176% | $0.98 | $24,500 | -46.99% | ||
| 2013-12-04 | Galectin Therapeutics Inc. GALT | director | 6,000 0.0357% | $8.69 | $52,140 | +30.03% | ||
| 2011-10-18 | Galectin Therapeutics Inc. GALT | director | 40,000 0.055% | $0.96 | $38,400 | -47.08% | ||
| 2010-12-10 | Curis, Inc. CRIS | director | 26,596 0.0355% | $1.89 | $50,266 | +73.55% |